<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03416920</url>
  </required_header>
  <id_info>
    <org_study_id>2017P002582</org_study_id>
    <nct_id>NCT03416920</nct_id>
  </id_info>
  <brief_title>A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease Risk</brief_title>
  <official_title>A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wellframe, Inc</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to evaluate Wellframe, a patient engagement platform that includes a
      mobile phone application for patients, for its impact on supporting patients who have
      undergone a percutaneous coronary intervention. The patient mobile app has articles about
      cardiovascular disease and other health related topics, patient-reported outcomes surveys,
      physical activity tracking, reminders for medications and upcoming appointments, and two-way
      communication with a Wellframe Health Advocate. The Wellframe Health Advocate encourages
      patients to achieve their health goals and stay engaged in their health. The feasibility of
      onboarding patients to the app and the clinical efficacy of the platform will be evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 12, 2018</start_date>
  <completion_date type="Anticipated">February 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Enroll and onboard 150 patients with the Wellframe application</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Readmission Rate 30 day</measure>
    <time_frame>30 Days</time_frame>
    <description>How many subjects were readmitted to the hospital</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Readmission Rate 90 day</measure>
    <time_frame>90 Days</time_frame>
    <description>How many subjects were readmitted to the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Enrollment in clinic-based cardiac rehab</measure>
    <time_frame>90 days</time_frame>
    <description>Percent of patients discharged after intervention who attend at least one session of clinic-based cardiac rehab</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Percutaneous Coronary Intervention</condition>
  <arm_group>
    <arm_group_label>Wellframe</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in this arm will use the Wellframe application for 90 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Wellframe</intervention_name>
    <description>Wellframe mobile phone app</description>
    <arm_group_label>Wellframe</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        English-speaking PCI: balloon angioplasty, bare-metal stent, or drug-eluting stent at MGH
        Smartphone or Tablet (iOS or Android)

        Exclusion Criteria:

        Recent (within 1mo) illicit substance use or alcohol abuse In-hospital AMI Known pregnancy
        Dementia or cognitive disability Incarceration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pradeep Natarajan, MD, MMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Phoebe Finneran, BS</last_name>
    <phone>6177261256</phone>
    <email>pfinneran1@mgh.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachusetss General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Phoebe Finneran, BS</last_name>
      <phone>617-726-1256</phone>
      <email>pfinneran1@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Pradeep Natarajan, MD, MMSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2018</study_first_submitted>
  <study_first_submitted_qc>January 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2018</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Pradeep Natarajan</investigator_full_name>
    <investigator_title>Director of Preventative Cardiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

